Editorial: Cancer therapy: The challenge of handling a double-edged sword

Bibliographic Details
Main Authors: Kulmira Nurgali, John A. Rudd, Halina Was, Raquel Abalo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1007762/full
_version_ 1818051344971333632
author Kulmira Nurgali
Kulmira Nurgali
Kulmira Nurgali
John A. Rudd
John A. Rudd
Halina Was
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
author_facet Kulmira Nurgali
Kulmira Nurgali
Kulmira Nurgali
John A. Rudd
John A. Rudd
Halina Was
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
author_sort Kulmira Nurgali
collection DOAJ
first_indexed 2024-12-10T11:07:53Z
format Article
id doaj.art-a8921536b38a423abb5fc4587d73c21d
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-10T11:07:53Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-a8921536b38a423abb5fc4587d73c21d2022-12-22T01:51:30ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-09-011310.3389/fphar.2022.10077621007762Editorial: Cancer therapy: The challenge of handling a double-edged swordKulmira Nurgali0Kulmira Nurgali1Kulmira Nurgali2John A. Rudd3John A. Rudd4Halina Was5Raquel Abalo6Raquel Abalo7Raquel Abalo8Raquel Abalo9Raquel Abalo10Institute for Health and Sport, Victoria University, Melbourne, VIC, AustraliaDepartment of Medicine Western Health, University of Melbourne, Melbourne, VIC, AustraliaRegenerative Medicine and Stem Cells Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC, AustraliaSchool of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, ChinaThe Laboratory Animal Services Centre, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, ChinaLaboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine, Warsaw, PolandÁrea de Farmacología y Nutrición, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos (URJC), Alcorcón, SpainUnidad Asociada I+D+i del Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, SpainHigh Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut-URJC), URJC, Alcorcón, Spain0Grupo de Trabajo de Ciencias Básicas en Dolor y Analgesia de la Sociedad Española del Dolor, Madrid, Spain1Grupo de Trabajo de Cannabinoides de la Sociedad Española del Dolor, Madrid, Spainhttps://www.frontiersin.org/articles/10.3389/fphar.2022.1007762/fullcancerchemotherapyimmunotherapyside effectssequelae
spellingShingle Kulmira Nurgali
Kulmira Nurgali
Kulmira Nurgali
John A. Rudd
John A. Rudd
Halina Was
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
Editorial: Cancer therapy: The challenge of handling a double-edged sword
Frontiers in Pharmacology
cancer
chemotherapy
immunotherapy
side effects
sequelae
title Editorial: Cancer therapy: The challenge of handling a double-edged sword
title_full Editorial: Cancer therapy: The challenge of handling a double-edged sword
title_fullStr Editorial: Cancer therapy: The challenge of handling a double-edged sword
title_full_unstemmed Editorial: Cancer therapy: The challenge of handling a double-edged sword
title_short Editorial: Cancer therapy: The challenge of handling a double-edged sword
title_sort editorial cancer therapy the challenge of handling a double edged sword
topic cancer
chemotherapy
immunotherapy
side effects
sequelae
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1007762/full
work_keys_str_mv AT kulmiranurgali editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT kulmiranurgali editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT kulmiranurgali editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT johnarudd editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT johnarudd editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT halinawas editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT raquelabalo editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT raquelabalo editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT raquelabalo editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT raquelabalo editorialcancertherapythechallengeofhandlingadoubleedgedsword
AT raquelabalo editorialcancertherapythechallengeofhandlingadoubleedgedsword